首页 | 本学科首页   官方微博 | 高级检索  
检索        

胎儿LAK细胞治疗中晚期肝癌的疗效观察
引用本文:祁岩超,尚佳.胎儿LAK细胞治疗中晚期肝癌的疗效观察[J].中国肿瘤临床,1994,21(6):405-407.
作者姓名:祁岩超  尚佳
作者单位:河南省肿瘤研究所!郑州市450003(祁岩超,王艳,王燕芳,焦宏,张小敏),河南省人民医院(尚佳,李怀斌,张延瑞,韩双印,刘福生,樵风桂,贾百灵)
摘    要:自1989年1月至1991年10月,我们应用6~7个月龄的胎儿脾脏细胞和白细胞介素-2(IL-2)共培养3天后制备成胎儿LAK细胞,静脉输注或肝动脉插管灌注治疗中晚期肝癌18例.结果疼痛减轻16例,占88.9%;食欲增加14例,占77%;临床完全缓解2例,占11%;部分缓解14例,占77%;总有效率占88.9%(16/18).而且LAK细胞治疗后患者周围血OKT_4比率升高,OKT_8比率下降,说明治疗后患者免疫功能有一定改善.结果提示:①胎儿脾脏含有丰富的LAK前身细胞;②胎儿LAK细胞治疗中晚期肝癌有明显疗效.

关 键 词:胎儿  LAK细胞  肝癌

The Effect of Fetal LAK Cells in the Treatment of Advanced Liver Cancer
Qi Yan-Chao et al Henan Provincial Tumor Institute,Zhengzhou.The Effect of Fetal LAK Cells in the Treatment of Advanced Liver Cancer[J].Chinese Journal of Clinical Oncology,1994,21(6):405-407.
Authors:Qi Yan-Chao Henan Provincial Tumor Institute  Zhengzhou
Abstract:From January 1989 to October 1991,18 patients with advanced liver cancer were treated with LAK cells from 6-7 months old fetus spleen cells cultured with IL-2 for 3 days. The LAK cells were given intravenously or via hepatic arterial infusion. Pain relief was seen in 16 cases(88. 9%) .appetite bettered off in 14 cases(77%);CR of tumor was seen in 2 cases(11%)(PR in 14 cases(77%). An overall response rate of 88. 9% (16/18)was achieved. The fact that the ratio of OKT4 in peripheral blood of patient treated with LAK cells increased and the ratio of OKT8 declined,demonstrated enhancement of immunity after treatment. It is concluded that(1)There are abundant pre-LAK cells in fetal spleem(2)Fetal LAK cells has significant therapeutic effect in advanced liver cancer.
Keywords:Fetal LAK cells Liver cancer Spleen cells
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号